Table 3.
Histology | Age | Sex | Site | Arpp | HHF35 | Myoglobin | Desmin | Carp |
---|---|---|---|---|---|---|---|---|
1. Alveolar | 38 | M | Nasal | ++ | ++ | + | + | ++ |
2. Alveolar | 7 | F | Muscle | ++ | + | +/− | + | ++ |
3. Alveolar | 20 | F | ++ | + | + | NT | ++ | |
4. Alveolar | 2 | F | Nasal | + | ++ | + | + | NT |
5. Alveolar | 3 | F | Nasal | ++ | ++ | − | + | NT |
6. Alveolar | 16 | M | Hip | + | ++ | + | ++ | ++ |
7. Embryonal | 48 | M | Soft tissue | ++ | ++ | + | + | ++ |
8. Embryonal | 18 | M | Lymph node | ++ | + | +/− | + | ++ |
9. Embryonal/botryoid | 1.8 | M | Ureter | ++ | ++ | + | +/− | ++ |
10. Embryonal/botryoid | 55 | M | Rectum/bladder | + | + | + | + | ++ |
11. Embryonal | 12 | F | Soft tissue | + | ++ | + | + | ++ |
12. Embryonal | 25 | M | Soft tissue | + | ++ | + | NT | ++ |
13. Embryonal | 8 | M | Bladder | + | ++ | +/− | +/− | ++ |
14. Embryonal | 4 | M | Lung | +/− | ++ | +/− | + | + |
15. Embryonal | 22 | F | Maxillary | + | ++ | − | ++ | NT |
16. Embryonal | 4 | M | Pelvic cavity | ++ | − | − | +/− | NT |
17. Embryonal | 13 | M | Hand | ++ | ++ | − | + | NT |
18. Embryonal | 8 | M | Retroperitoneum | + | ++ | − | + | NT |
19. Pleomorphic | 26 | M | Prostate/bladder | + | ++ | + | + | ++ |
20. Pleomorphic | 20 | F | Leg | ++ | ++ | + | ++ | NT |
21. Pleomorphic | 48 | F | Thigh | + | ++ | − | ++ | NT |
22. Pleomorphic | 53 | M | Lumbar region | ++ | ++ | +/− | ++ | + |
23. Pleomorphic | 62 | F | Ovary | ++ | ++ | + | + | ++ |
24. Pleomorphic | 38 | M | Cervical region | + | ++ | +/− | ++ | NT |
Immunoreactivities were classified based on the Arpp-positive rate. ++, <50%; +, 5 to 50%; +/−, 0 to 5%; −, unstained.
NT, Not tried.